Development and application of a graded evidence framework for the association between gut microbiota-derived metabolites and diabetic retinopathy
Year: 2026
Type: article
Study design: Systematic Review
Abstract: Objective The gut–retina axis hypothesis suggests that microbial metabolites contribute to diabetic retinopathy (DR); however, the existing evidence remains heterogeneous, and no systematic grading framework has been established to date. We developed a four-tier (I–IV) evidence-grading framework specifically tailored to the gut–retina axis. Methods The framework was adapted from established methodologies, including the Systematic Review and Integrated Assessment (SYRINA), the Evidence Integration Framework (EIF), and the International Agency for Research on Cancer (IARC) Preamble, with prespecified criteria for assessing metabolite–DR associations. Systematic searches in PubMed, Scopus, Embase, and Web of Science (2001–2026) identified 29 original studies. Two reviewers independently graded the evidence, with substantial inter-rater agreement (Cohen’s κ = 0.89). Results None of the 17 metabolites met Level I criteria. Valine attained Level II-B, supported by Mendelian randomization (MR) evidence for a composite DR endpoint (OR = 1.51, 95% CI: 1.31–1.76; statistically significant after Bonferroni correction (P < 3.78 × 10 -5 ); exact P not reported). Level III (suggestive) comprised three metabolites: SCFA deficiency, TMAO, and LPS; TUDCA was classified as III-conflicting. Level IV (exploratory) included 12 metabolites: ImP, colibactin, virome, fungal microbiota, PCS, H 2 S, UDCA, BCAAs, IPA, PAGln, IS, and MGO. Conclusion MR studies are needed for most substances to establish causal evidence. The evidence map provides a proof-of-concept demonstration (version 1.0). Grades are hypothesis-generating; external validation is required before clinical use. Systematic review registration https://doi.org/10.17605/OSF.IO/D48Z2 , identifier 10.17605/OSF.IO/D48Z2
Source: Frontiers in Endocrinology
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: diabetic retinopathy, gut microbiota metabolites, gut-retina axis, valine, short-chain fatty acids, trimethylamine N-oxide, lipopolysaccharide, tauroursodeoxycholic acid, branched-chain amino acids, hydrogen sulfide, colibactin, gut virome, fungal microbiota, evidence map, Mendelian randomization
Open Access status: gold
Estimated APC paid: $3,801
Award: G9001368765
OpenAlex ID: W7225995789
